Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma

doi:10.3748/wjg.v25.i46.6767

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7141)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

1042

WORD

163

HTML

3651

Figures (1-2)

227

Tables (1-6)

173

Sum=5256

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

837

Download

1048

Sum=1885

Dec 14, 2019 (publication date) through Jul 7, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 14, 2019; 25(46): 6767-6780
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6767

Table 6 Diagnostic performance for lesions indicated for surgery or chemoradiotherapy by Fluorodeoxyglucose positron emission tomography alone and Fluorodeoxyglucose positron emission tomography combined with magnifying endoscopy-narrow band imaging

	FDG-PET	FDG-PET + ME-NBI	P value
Sensitivity	78.3% (18/23)	78.3% (18/23)	1.00
Specificity	81.4% (48/59)	91.5% (54/59)	0.12
PPV	62.1% (18/29)	78.3% (18/23)	0.24
NPV	90.6% (48/53)	91.5% (54/59)	0.86
Accuracy	80.5% (66/82)	87.8% (72/82)	0.20

CRT: Chemoradiotherapy; ME-NBI: Magnifying endoscopy-narrow band imaging; FDG-PET: Fluorodeoxyglucose positron emission tomography; PPV: Positive predictive value; NPV: Negative predictive value.

Citation: Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(46): 6767-6780
URL: https://www.wjgnet.com/1007-9327/full/v25/i46/6767.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i46.6767